Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2023.1373
Abstract: Importance Titanium-nitride-oxide (TiNO)-coated stents show faster strut coverage compared with drug-eluting stents without excessive intimal-hyperplasia observed in bare metal stents. It is important to study long-term clinical outcomes after treatment of patients with an acute… read more here.
Keywords: outcome; trial; tino; eluting stents ... See more keywords
Comparison of two biodegradable‐polymer‐based sirolimus‐eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26918
Abstract: Implantation of early‐generation metallic drug‐eluting stents (DES) in patients with acute myocardial infarction (AMI) is associated with poor vessel wall healing. Use of biodegradable polymer (BP) DES might improve safety outcomes; however, the impact of… read more here.
Keywords: absorption kinetics; eluting stents; patients acute; biodegradable polymer ... See more keywords
Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York
Sign Up to like & getrecommendations! Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27000
Abstract: To evaluate long‐term outcomes in patients undergoing either paclitaxel‐eluting stents (PES) or endeavor zotarolimus‐eluting stents (E‐ZES) placement and to assess comparative effectiveness of PES vs. E‐ZES in different “off‐label” and “high‐risk” patient subgroups. read more here.
Keywords: endeavor zotarolimus; zotarolimus eluting; paclitaxel eluting; eluting stents ... See more keywords
Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27809
Abstract: To compare the effectiveness and safety of self‐expandable, sirolimus‐eluting Stentys stents (SES) and second‐generation drug‐eluting stents (DES‐II) for the treatment of the unprotected left main (ULM). read more here.
Keywords: self expandable; eluting stents; expandable sirolimus; sirolimus eluting ... See more keywords
Hybrid‐stenting with metallic and bioresorbable drug‐eluting stents 2‐year clinical outcomes in KUM ABSORB registry
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27832
Abstract: We sought to investigate and compare outcomes 2 years after Hybrid‐stenting with bioresorbable vascular scaffolds (BVS) and contemporary metallic drug‐eluting stents (DES) within the same coronary lesion versus BVS alone. read more here.
Keywords: drug eluting; eluting stents; stenting metallic; hybrid stenting ... See more keywords
Comparison of neointimal coverage between durable‐polymer everolimus‐eluting stents and bioresorbable‐polymer everolimus‐eluting stents 1 year after implantation using high‐resolution coronary angioscopy
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28095
Abstract: We aimed to compare the coronary angioscopic appearance of neointimal coverage (NIC) over durable‐polymer everolimus‐eluting stents (XIENCE‐EES) and bioresorbable‐polymer everolimus‐eluting stents (SYNERGY‐EES) 1 year after implantation. read more here.
Keywords: polymer everolimus; eluting stents; everolimus eluting; neointimal coverage ... See more keywords
Long‐term outcome in patients treated with first‐ versus second‐generation drug‐eluting stents for the treatment of unprotected left main coronary artery stenosis
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28387
Abstract: The study aim is to provide long‐term clinical outcome after percutaneous coronary intervention (PCI) for unprotected left main coronary arteries (ULMCA) stenosis with the first‐generation (1st‐gen) drug‐eluting stents (DES) in comparison to 2nd‐gen DES, since… read more here.
Keywords: left main; drug eluting; eluting stents; long term ... See more keywords
Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28833
Abstract: The TAXCO study was designed to compare the degree of neointimal coverage and the prevalence of malapposition at 6 months subsequent to implantation of ultrathin biodegradable polymer‐coated sirolimus‐eluting stents (SES) and durable polymer‐coated everolimus‐eluting stents… read more here.
Keywords: eluting stents; neointimal coverage; polymer coated; ultrathin biodegradable ... See more keywords
Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29225
Abstract: The present study aims to analyze the angiographic anti‐restenotic performance of durable polymer everolimus‐eluting stents (EES) for the treatment of in‐stent restenosis (ISR) in daily practice. read more here.
Keywords: eluting stents; stent restenosis; performance; everolimus eluting ... See more keywords
Short‐term dual antiplatelet therapy for 1–3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta‐analysis of randomized clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30521
Abstract: The optimal dual antiplatelet therapy (DAPT) duration and regimen in patients undergoing percutaneous coronary intervention (PCI) using current generation drug eluting stents (DES) is still unclear. read more here.
Keywords: drug eluting; percutaneous coronary; eluting stents; coronary intervention ... See more keywords
Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug-eluting stents in Germany and Italy.
Sign Up to like & getrecommendations! Published in 2022 at "Health economics"
DOI: 10.1002/hec.4587
Abstract: We investigated the role of spillover effects among hospitals in the diffusion of drug-eluting stents (DES) in Germany and Italy during a period in which the relevant medical guideline clearly recommended their use over bare-metal… read more here.
Keywords: spillover effects; drug eluting; guideline; eluting stents ... See more keywords